Heptakis(1-hexyl-3-methylimidazol-3-ium);borate;tetrafluoride
C70H133BF4N14O3 — CID 175093615
Data last refreshed: (MolForge compound catalog, from PubChem)
About Heptakis(1-hexyl-3-methylimidazol-3-ium);borate;tetrafluoride
Heptakis(1-hexyl-3-methylimidazol-3-ium);borate;tetrafluoride (PubChem CID 175093615) has the molecular formula C70H133BF4N14O3 and a molecular weight of 1305.73 g/mol. Its IUPAC name is heptakis(1-hexyl-3-methylimidazol-3-ium);borate;tetrafluoride.
Molecular Properties
| Compound Name | Heptakis(1-hexyl-3-methylimidazol-3-ium);borate;tetrafluoride |
|---|---|
| PubChem CID | 175093615 |
| Molecular Formula | C70H133BF4N14O3 |
| Molecular Weight | 1305.73 g/mol |
| Exact Mass | 1305.07 |
| IUPAC Name | heptakis(1-hexyl-3-methylimidazol-3-ium);borate;tetrafluoride |
| SMILES | CCCCCCn1cc[n+](C)c1.CCCCCCn1cc[n+](C)c1.CCCCCCn1cc[n+](C)c1.CCCCCCn1cc[n+](C)c1.CCCCCCn1cc[n+](C)c1.CCCCCCn1cc[n+](C)c1.CCCCCCn1cc[n+](C)c1.[F-].[F-].[F-].[F-].[O-]B([O-])[O-] |
| InChI | InChI=1S/7C10H19N2.BO3.4FH/c7*1-3-4-5-6-7-12-9-8-11(2)10-12;2-1(3)4;;;;/h7*8-10H,3-7H2,1-2H3;;4*1H/q7*+1;-3;;;;/p-4 |
| InChIKey | ZWOUNKQSLRLPCN-UHFFFAOYSA-J |
| XLogP | -2.68 |
| TPSA | 130.85 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 92 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 1305.73 |
| LogP ≤ 5 | -2.68 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175093615 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.